Fifth Third Bancorp
CPRX

Fifth Third Bancorp’s Catalyst Pharmaceutical CPRX Stock Holding History

Fifth Third Bancorp’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$835K Sell
26,571
-1,797
-6% -$53K ﹤0.01% 1805
2026
Q1 		$702K Buy
28,368
+27,778
+4,708% +$662K ﹤0.01% 1845
2025
Q4 		$13.8K Buy
590
+19
+3% +$423 ﹤0.01% 2032
2025
Q3 		$11.2K Sell
571
-69
-11% -$1.42K ﹤0.01% 2101
2025
Q2 		$13.9K Sell
640
-10
-2% -$236 ﹤0.01% 1908
2025
Q1 		$15.8K Buy
650
+212
+48% +$4.77K ﹤0.01% 1846
2024
Q4 		$9.14K Buy
438
+10
+2% +$215 ﹤0.01% 2002
2024
Q3 		$8.51K Buy
428
+55
+15% +$1.02K ﹤0.01% 2044
2024
Q2 		$5.78K Buy
373
+53
+17% +$825 ﹤0.01% 2085
2024
Q1 		$5.1K Buy
320
+12
+4% +$181 ﹤0.01% 2051
2023
Q4 		$5.18K Buy
308
+86
+39% +$1.18K ﹤0.01% 2178
2023
Q3 		$2.6K Hold
222
– – ﹤0.01% 2338
2023
Q2 		$2.98K Hold
222
– – ﹤0.01% 2345
2023
Q1 		$3.68K Buy
+222
New +$3.66K ﹤0.01% 2424
2021
Q1 		– Sell
-1,000
Closed -$3K – 2423
2020
Q4 		$3K Hold
1,000
– – ﹤0.01% 2168
2020
Q3 		$3K Buy
+1,000
New +$3.91K ﹤0.01% 1958

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fifth Third Bancorp's CPRX Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Catalyst Pharmaceutical (CPRX) stake by 6.3% in Q2 2026, selling an estimated $53K and leaving 26,571 shares worth $835K. The position accounts for ﹤0.01% of the portfolio, ranked #1805.

Fifth Third Bancorp first reported a position in CPRX in Q3 2020 and has held it in 16 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Fifth Third Bancorp held 26,571 shares of Catalyst Pharmaceutical worth $835K as of Q2 2026.
  • Fifth Third Bancorp sold 1,797 Catalyst Pharmaceutical shares in Q2 2026, an estimated $53K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1805 holding.
  • Fifth Third Bancorp first reported a position in Catalyst Pharmaceutical in Q3 2020 and has held it in 16 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.